Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.75
+0.70 (3.49%)
Nov 13, 2026, 1:30 PM CST

Formosa Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,1333,9865,6546,7005,9213,390
Market Cap Growth
-23.99%-29.51%-15.62%13.17%74.66%-
Enterprise Value
2,1482,4994,0175,4725,8002,937
Last Close Price
20.7526.4037.4549.9550.5932.95

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
60.63419.7839.44214.954502.47118.82
PB Ratio
2.462.743.655.8812.678.62
P/TBV Ratio
3.734.014.698.77105.56-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
41.56263.2128.02175.534410.71102.95

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.030.020.01
Net Debt / Equity Ratio
-0.77-0.97-1.05-1.04-0.89-0.52
Net Debt / EBITDA Ratio
6.1611.0211.574.791.200.60
Net Debt / FCF Ratio
2.0713.3911.925.991.200.62
Asset Turnover
0.030.010.080.020.000.05
Inventory Turnover
5.443.14----
Quick Ratio
22.358.828.574.896.2611.55
Current Ratio
27.559.118.734.996.5612.15
Return on Equity (ROE)
-16.81%-5.56%-14.94%-40.04%-94.39%-135.15%
Return on Assets (ROA)
-6.48%-5.10%-5.72%-13.58%-30.45%-41.28%
Return on Capital Employed (ROCE)
-11.30%-9.00%-9.20%-19.30%-47.20%-56.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.36%-2.10%-3.55%-4.81%-6.86%-11.83%
FCF Yield
-15.22%-2.65%-2.40%-2.96%-5.85%-9.78%
Buyback Yield / Dilution
-3.00%-7.22%-13.48%-18.00%-13.70%-31.19%